AIT Corp reported a net profit of 789 million yen for the first quarter ending May 31, falling short of the 870 million yen recorded during the same period last year. Despite a modest rise in top-line revenue, the company faced mounting pressure on its overall earnings per share.
AstraZeneca has secured exclusive global rights to the lung cancer therapy Zegfrovy in a deal worth up to $1.5 billion, triggering a 20% surge in Dizal Pharmaceutical’s stock price. The agreement provides an immediate $600 million influx for the Shanghai-based developer, signaling a major endorsement of its oncology pipeline.
Rio Tinto shipped 85.3 million metric tons of iron ore from its Pilbara operations during the second quarter, marking a 7% year-over-year increase. This performance exceeded analyst expectations of 83.4 million tons, signaling a robust recovery from weather-related disruptions that hampered the company’s Australian mines earlier this year.
A sharp rise in demand pushed West Holdings Corp. to a net profit of 2.32 billion yen for the nine-month period ending May 31, nearly tripling the 775 million yen recorded during the same timeframe last year. The results reflect significant operational gains across the company's core business sectors.
Global pulp markets have claimed another casualty as Canfor announced the closure of its Northwood mill in British Columbia. The move, triggered by an unrelenting oversupply and a scarcity of raw fibre, will result in the loss of 300 jobs and a significant reduction in regional production capacity.
Investors will turn their attention to Veradermics on Wednesday morning as the biopharmaceutical firm prepares to disclose findings from the female treatment arms of its phase 2 study. The company plans to detail performance metrics for VDPHL01, an extended-release version of minoxidil, during an 8 a.m. conference call.
A 13% drop in after-hours trading for Pentair followed the company’s decision to slash its annual revenue outlook and announce the immediate resignation of its chief financial officer. The slump reflects a broader cooling in demand for pool equipment that has rattled investor confidence in the firm's near-term performance.
A sharp contraction in the pool segment has forced Pentair to downgrade its financial projections, signaling a departure from earlier growth targets. The water treatment firm now expects second-quarter revenue to reach $930 million, a 17% drop from its previous guidance, while full-year outlooks have shifted into negative territory.
Churchill Capital Corp IX is set to dissolve after failing to secure a business combination before its mandated deadline. The blank-check company confirmed it will liquidate its assets and redeem all outstanding public shares, bringing an abrupt end to its tenure on the Nasdaq exchange.
A 30% jump in after-hours trading greeted Aehr Test Systems on Tuesday as the semiconductor equipment manufacturer shifted from a deep deficit to a quarterly profit. The stock climbed to $94.11, shattering its regular session close of $72.01 following a robust report for the period ending May 29.
Rising oil prices triggered a sell-off in communications services today, casting a shadow over the sector as investors recalibrate their portfolios. The broader market downturn reflects growing anxiety over energy-driven inflation, forcing telecom firms to navigate a tightening economic environment that threatens to squeeze corporate margins.
The power sector stalled in early trading as a cooling inflation report pushed Treasury yields downward. While the broader market reacted to the softer economic data, investors remained cautious, keeping utility stocks near their opening levels as the Federal Reserve reaffirmed its commitment to aggressive price stability measures.
A sharp rebound in semiconductor stocks provided a floor for the technology sector, even as IBM suffered a massive sell-off and New York moved to curb the physical footprint of the artificial intelligence boom through a moratorium on large-scale data center construction.
Stan Guidroz is stepping into the role of chief operating officer at Accel Entertainment, effective immediately. He replaces Mark Phelan, who shifts his focus toward the chief executive position starting this August, marking a significant leadership transition for the gaming operator as it looks to solidify its market footprint.
A sharp deceleration in inflation data combined with a cascade of blowout earnings from the nation’s largest financial institutions propelled U.S. markets higher on Tuesday. While the broader indices climbed, a profit warning from IBM acted as a persistent drag on the Dow, tempering the overall upward momentum.
With $255.8 million in total funding already secured, biopharmaceutical developer Attovia Therapeutics has formally filed for an initial public offering. The company intends to list on the Nasdaq Global Market under the ticker symbol ATTO, according to regulatory documents submitted to the Securities and Exchange Commission on Tuesday.
Leica Biosystems is set to acquire StatLab Medical Products, a move aimed at bolstering the diagnostic capabilities of the Danaher Corp. subsidiary. By integrating StatLab’s anatomical pathology portfolio, the company intends to establish the standardized laboratory workflows necessary to deploy artificial intelligence for large-scale cancer diagnostics.
CVS Caremark has reached a sweeping global settlement with the Federal Trade Commission to resolve long-standing litigation over its pharmacy benefit management practices. The agreement forces the company to implement significant changes to its pricing structure and rebate policies, aiming to lower patient out-of-pocket costs by billions over the next decade.
Industrial and transportation stocks held steady as investors recalibrated their portfolios against shifting inflation expectations. While major indices remained largely unmoved, individual volatility surfaced within the sector as companies grappled with high-stakes financial restructuring, international trade surges, and the looming threat of global competition.
After two decades of research into the elusive PAM pathway, Celcuity has received FDA approval for Revtorpyk, a novel treatment for HR+/HER2- breast cancer. The drug, known generically as gedatolisib, marks a significant shift in therapy for patients who have exhausted initial endocrine options without specific PIK3CA mutations.
A sudden military escalation between the United States and Iran has sent global energy markets into a frenzy, with oil futures climbing over 11% in just two sessions. The confrontation, triggered by strikes on three tankers near the Strait of Hormuz, marks the sharpest two-day rally since April.
Investors pushed Schmid Group shares 5.1% higher to $4.75 in after-hours trading Tuesday, reacting to an upward revision in the company's full-year order intake projections. The jump arrives as a welcome shift for shareholders, following a 27% decline in the stock's value since the start of the year.
Gold futures surged toward the $4,000-per-troy-ounce threshold as geopolitical friction between the United States and Iran escalated over the weekend. This flight to safety, combined with shifting inflationary expectations, prompted a broad uptick in metal and grain production values as traders recalibrated their portfolios against lingering economic uncertainty.
A sharp downward correction hit the health-care sector today after HCA Healthcare slashed its annual profit projections. The hospital operator cited volatile shifts in patient coverage under the Affordable Care Act, sparking a broader retreat among investors already wary of upcoming earnings reports from major pharmaceutical manufacturers.
A 39% year-over-year earnings jump propelled financial stocks upward this week, as major lenders shattered analyst expectations. JPMorgan Chase, Goldman Sachs, Bank of America, Citigroup, and Wells Fargo collectively cleared $49 billion in profit, buoyed by a broad recovery across trading, investment banking, and consumer lending sectors.
A 15% drop in after-hours trading greeted Wabash National on Tuesday, as investors reacted to the company’s surprise announcement of a $100 million convertible senior unsecured note offering. The sharp decline erased earlier gains, pulling the stock down to $11.40 following a regular session that had closed at $13.42.
Rising oil futures are rattling investors, pushing consumer stocks into the red even as the latest inflation data offers a glimmer of relief. While the consumer price index retreated for the first time since 2020, geopolitical tensions near the Strait of Hormuz are threatening to erase those hard-won gains at the pump.
A cooling inflation report of 3.5% for June has fundamentally altered market expectations, with investors slashing the probability of an imminent interest-rate hike from 42% to 16%. This shift, paired with robust earnings from major financial institutions, provided a rare moment of stability amid broader volatility across the exchanges.
Zoetis has moved to acquire VitalRADS, folding the teleradiology platform into its broader animal-health services portfolio. The deal follows a 2025 partnership between the two entities, though the financial specifics of the acquisition remain undisclosed as the firm seeks to bolster its diagnostic capabilities through integrated AI and specialist access.
Lucid Group pushed back against market speculation Tuesday, asserting that its current liquidity remains sufficient to fund operations well into 2027. The electric vehicle maker explicitly denied the existence of any special board committee tasked with exploring restructuring scenarios, aiming to calm investor fears despite a volatile trading session.
